Table 2 Key model inputs
Trial registration identifier | Group | Endpoint | Survival model | Parameter | |
|---|---|---|---|---|---|
Scale | Shape | ||||
NCT01761266 | Lenvatinib | PFS | Log-logistic | 7.00 | 1.68 |
OS | Log-logistic | 13.62 | 1.77 | ||
Sorafenib | PFS | Log-logistic | 4.21 | 1.56 | |
OS | Log-logistic | 12.52 | 1.59 | ||
NCT03434379 | Atezolizumab-Bevacizumab | PFS | Weibull | 0.08 | 1.09 |
OS | Log-logistic | 21.03 | 1.32 | ||
NCT03794440 | Sintilimab-Bevacizumab | PFS | Log-logistic | 4.85 | 1.35 |
OS | Log-logistic | 15.88 | 1.71 | ||